Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Buggert

Showing results (71-80 of 126) with videos related to

Pageof 13
Sort By:
Science Immunology|September 14, 2021
Identification of resident memory CD8<sup>+</sup> T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissueJulia Niessl, Takuya Sekine, Joshua Lange, et al.
Frontiers in Immunology|January 27, 2023
Persistence of salivary antibody responses after COVID-19 vaccination is associated with oral microbiome variation in both healthy and people living with HIVMahin Ghorbani, Khaled Al-Manei, Sabrina Naud, et al.
Haematologica|August 30, 2023
Systemic and mucosal adaptive immunity to SARS-CoV-2 during the Omicron wave in patients with chronic lymphocytic leukemiaHanna M Ingelman-Sundberg, Lisa Blixt, David Wullimann, et al.
Nature Medicine|January 18, 2022
Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variantYu Gao, Curtis Cai, Alba Grifoni, et al.
Cell Host & Microbe|May 26, 2023
Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpoxSarah Adamo, Yu Gao, Takuya Sekine, et al.
Science Immunology|December 8, 2023
SARS-CoV-2 vaccination enhances the effector qualities of spike-specific T cells induced by COVID-19Curtis Cai, Yu Gao, Sarah Adamo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2023
Functional SARS-CoV-2 cross-reactive CD4<sup>+</sup> T cells established in early childhood decline with ageMarion Humbert, Anna Olofsson, David Wullimann, et al.
Molecular Therapy. Advances|May 15, 2026
A phase 1 clinical trial of a multi-antigen SARS-CoV DNA vaccine as a booster after dose three spike-based mRNA vaccinationsSoo Aleman, Gustaf Ahlén, Jingyi Yan, et al.
Ebiomedicine|July 15, 2023
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXIDPuran Chen, Peter Bergman, Ola Blennow, et al.
Molecular Medicine (Cambridge, Mass.)|May 13, 2022
MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccineCaroline Boulouis, Tobias Kammann, Angelica Cuapio, et al.
Pageof 13

Showing results (71-80 of 126) with videos related to

Sort By:
Pageof 13
Science Immunology|September 14, 2021
Identification of resident memory CD8<sup>+</sup> T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissueJulia Niessl, Takuya Sekine, Joshua Lange, et al.
Frontiers in Immunology|January 27, 2023
Persistence of salivary antibody responses after COVID-19 vaccination is associated with oral microbiome variation in both healthy and people living with HIVMahin Ghorbani, Khaled Al-Manei, Sabrina Naud, et al.
Haematologica|August 30, 2023
Systemic and mucosal adaptive immunity to SARS-CoV-2 during the Omicron wave in patients with chronic lymphocytic leukemiaHanna M Ingelman-Sundberg, Lisa Blixt, David Wullimann, et al.
Nature Medicine|January 18, 2022
Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variantYu Gao, Curtis Cai, Alba Grifoni, et al.
Cell Host & Microbe|May 26, 2023
Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpoxSarah Adamo, Yu Gao, Takuya Sekine, et al.
Science Immunology|December 8, 2023
SARS-CoV-2 vaccination enhances the effector qualities of spike-specific T cells induced by COVID-19Curtis Cai, Yu Gao, Sarah Adamo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2023
Functional SARS-CoV-2 cross-reactive CD4<sup>+</sup> T cells established in early childhood decline with ageMarion Humbert, Anna Olofsson, David Wullimann, et al.
Molecular Therapy. Advances|May 15, 2026
A phase 1 clinical trial of a multi-antigen SARS-CoV DNA vaccine as a booster after dose three spike-based mRNA vaccinationsSoo Aleman, Gustaf Ahlén, Jingyi Yan, et al.
Ebiomedicine|July 15, 2023
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXIDPuran Chen, Peter Bergman, Ola Blennow, et al.
Molecular Medicine (Cambridge, Mass.)|May 13, 2022
MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccineCaroline Boulouis, Tobias Kammann, Angelica Cuapio, et al.
Pageof 13